Analysts/Institutional Investor Meet/Con. Call Updates

August 08, 2026 BSE Limited National Stock Exchange of India Limited P.J. Tower, Exchange Plaza, Dalal Street, Fort, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 544645 SYMBOL: PARKHOSPS Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)- Transcript of Earnings Conference Call Dear Sir/Madam, Pursuant to the provisions of Regulation 30 of Listing Regulations, please find enclosed transcript of the Earnings Conference Call held on August 04, 2026 for Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The transcript is also being disseminated on the Company's website at https://www.parkhospital.in/ This is for your information and records. Thanking you, For and on behalf of Park Medi World Limited Name: Abhishek Kapoor Designation: Company Secretary & Compliance Officer Encl: A/a “Park Medi World Limited Q1 FY’27 Earnings Conference Call” August 04, 2026 SPEAKERS: DR. ANKIT GUPTA – MANAGING DIRECTOR, PARK MEDI WORLD LIMITED DR. SANJAY SHARMA – WHOLE-TIME DIRECTOR & CHIEF EXECUTIVE OFFICER, PARK MEDI WORLD LIMITED MR. RAJESH SHARMA – GROUP CHIEF FINANCIAL OFFICER, PARK MEDI WORLD LIMITED MR. SUDESH SHARMA – CHIEF STRATEGY OFFICER & OSD (FINANCE), PARK MEDI WORLD LIMITED MS. SALONI NAGVEKAR – ADFACTORS PR – INVESTOR RELATIONS This transcript has been edited for factual errors Page 1 of 18 Park Medi World Limited August 04, 2026 Moderator: Ladies and Gentlemen, Good Day and Welcome to the Park Medi World Limited Earnings Conference Call for Q1 FY’27. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing “*” then “0” on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Ms. Saloni Nagvekar from Adfactors PR. Thank you and over to you, ma'am. Saloni Nagvekar: Good Morning, Everyone and a Warm Welcome to Park Medi World Limited Earnings Conference Call for Q1 FY’27. From the Management Team, we have with us Dr. Ankit Gupta – Managing Director, Dr. Sanjay Sharma – Whole-Time Director and Chief Executive Officer, Mr. Rajesh Sharma – Group Chief Financial Officer and Mr. Sudesh Sharma – Chief Strategy Officer and OSD (Finance). We will begin with “Opening Remarks from the Management,” following which we will open the floor for “Q&A Session”. Before we begin, I would like to point out that some of the statements made on today's call may be forward-looking in nature and detailed disclaimer to that effect has been included in the earnings presentation shared with you earlier, which is now available on our website and on stock exchanges. I would now like to invite “Dr. Ankit Gupta – Managing Director, Park Medi World to begin with his Opening Remarks.” Over to you, sir. Dr. Ankit Gupta: Thank you. Good morning, everyone and thank you for joining us for Park Medi World Q1 FY’27 Earnings Call. On behalf of the Board and Management Team, I would thank you for your continued interest and support as we further build on what was in the form of Financial Year‘26, the strongest year in our company's history. Q1 FY27 has been a quarter of consolidation, growth and continuous execution. Our focus this quarter has been on ramping up our newer assets, Agra and Panchkula, while advancing the next leg of our growth pipeline across Uttarakhand, NCR and Punjab. On 25th May, we announced a definitive agreement to acquire 100% shareholding in The Medicity Hospital, Rudrapur, Uttarakhand in an all-cash transaction valued at approximately Rs.177 crores, marking our entry into the sixth state. The Medicity is a 330-bed NABH-accredited Multi-Super Page 2 of 18 Park Medi World Limited August 04, 2026 Speciality Hospital in the Kumaon region. I am pleased to report that the facility was commissioned this past Sunday on 2nd August, 2026. On 30th June, we announced a 100-bed extension at our Palam Vihar facility in Gurgaon under the name ’Park Platinum’, which will take our consolidated Gurgaon capacity to 750-beds. Our 200-bed hospital in Narela, acquired through an insolvency process, is also on track for commissioning. And yesterday on 3rd August 2026, we announced a definitive agreement to acquire Mehar Hospital, a 150-bedded Multi-Super Speciality Hospital in Zirakpur, serving the wider Tricity catchment, at a valuation of approximately Rs.107 crores. All three of these additions, 450-beds in total, are scheduled to commission in November and December 2026. Our total bed capacity stood at 3,960-beds as of 30th June, up 32% year-on-year. Taken together, our capacity addition during calendar year 2026 will be total 1,490 beds, an increase of 46% over our calendar year 2025, capacity of 3,250 beds. We expect to end financial year 2027 with 4,740 beds, with another 1,000 beds to be added in FY’28. We will be at 5,740 beds capacity by FY’28, funded largely through internal accruals and IPO proceeds, without recourse to any fresh debts. Our board approved the result for the quarter-ended 30th June at its meeting yesterday. We reported revenue from operations of Rs.476 crores, year-on-year growth of 19%. EBITDA, excluding other income, stood at Rs.126 crores, year-on-year growth of 20%, with a margin of 26.5%. PAT came in at Rs.89 crores, year-on-year growth of 35%, with a margin of 18.6%. All our operational metrics, including ARPOB, ALOS, ARPP and total patient volume, have also shown impressive performances. Now with that, I would like to hand over to Dr. Sanjay Sharma to take you through our operational performance in detail. Thank you. Dr. Sanjay Sharma: Thank you, Dr. Ankit and good morning, everyone. Let me walk you through our “Operating Metrices for Q1 FY’27.” IPD volumes for quarter stood at 26,304 patients, a growth of 16% year-on-year, while OPD volume came in at 2,23,446 patients, up by 17% year-on-year. ARPOB for the quarter was Rs.30,444 compared to Rs.27,221 in Q1 FY’26, an increase of 12% year- on-year, while ALOS improved 8% to 5.9 days from 6.4 days a year ago. Page 3 of 18 Park Medi World Limited August 04, 2026 On a case mix, our shift towards high-end tertiary and quaternary care continued. With high-end specialties contributing approximately 62% of the revenue, which is an increase of 440 basis points year-on-year. Our transplant, interventional cardiology, and robot-assisted joint replacement programs all continued to scale during the quarter, reflecting the increasing clinical depth of our network. Network occupancy for the quarter stood at 56% compared to 68% in Q1 FY’26. This reflects the step-up in capacity over the past 12-months. We have added 960-beds across Bhatinda 250, Agra 360, and Panchkula 350, which entered the denominator immediately while ramping up over several quarters. We expect full-year FY’27 occupancy to moderate from the FY’26 figures of 64%, largely on account of the addition of significant new capacity of 1,490-beds in calendar year 2026. Our Agra facility, commissioned in February 2026, and our Panchkula facility, commissioned in April 2026, are both ramping up in line with expectations. On the CGHS rate revision, while we had guided conservatively to a 7% to 7.5% benefit flowing into FY’27, we continue to expect the fuller impact to be visible from Q2 of the financial year as the revised rates percolate through allied central government agencies. On quality, all our operational hospitals continue to be NABH-accredited, and our recently commissioned Panchkula facility is progressing through its NABH accreditation process. Currently, we have now nine hospitals with NABL-accredited labs, up from eight hospitals earlier. We are planning to have four additional hospitals obtain NABL accre [Showing first 8,000 characters — download PDF for full document]